Executive Summary
NASA has fully obligated $471.6M to Caltech across two delivery orders for JPL FFRDC operations through mid-2027, with $400.8M (85%) already outlayed, signaling strong commitment to space R&D continuity. 100% concentration on one nonprofit entity underscores stable but undiversified funding model with neutral equity implications. Execution hinges on NASA task orders amid extended timelines.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior NASA & Space Contracts Intelligence digest from March 19, 2026.
Investment Signals (2)
- JPL Funding Locked Through 2027 (HIGH)▲
Full base + options ($471.6M) exercised across contracts ensures predictable R&D spend.
- Extreme Vendor Concentration (MEDIUM)▲
Both awards (100% of period value) to single nonprofit Caltech heightens single-point reliance.
Risk Flags (2)
- Execution [HIGH RISK]▼
Task order dependency from NASA Management Office--JPL required for work allocation.
- Market [MEDIUM RISK]▼
Extended terms to 2027 expose to NASA budget volatility.
Opportunities (2)
- ◆
Sustained FFRDC model with full $471.6M committed supports long-term space science stability.
- ◆
Follow-on potential under JPL sponsoring agreement for new missions.
Sector Themes (1)
- ◆
Caltech/JPL secures 100% of $471.6M in awards for core operations like DSN enhancements and science missions.
Watch List (2)
- 👁
{"entity"=>"Caltech/JPL", "reason"=>"Holds $471.6M (100%) in fully obligated NASA contracts through 2027.", "trigger"=>"Task order delays or 2027 extensions/recompetes"}
- 👁
{"entity"=>"NASA Management Office--JPL", "reason"=>"Controls task orders critical to $400.8M+ execution.", "trigger"=>"Accelerated outlays or new project taskings"}
Get daily alerts with 2 investment signals, 2 risk alerts, 2 opportunities and full AI analysis of all 2 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: NASA & Space Contracts Intelligence
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals
May 27, 2026
Big Pharma Approvals — May 27, 2026
Big Pharma Approvals